Malaria Journal

official impact factor 3.49
Search for
Advanced search
Malaria Journal
Tools
Share this article
Open Access

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children

Shereen Katrak, Anne Gasasira, Emmanuel Arinaitwe, Abel Kakuru, Humphrey Wanzira, Victor Bigira, Taylor G Sandison, Jaco Homsy, Jordan W Tappero, Moses R Kamya and Grant Dorsey*

Malaria Journal 2009, 8:272 doi:10.1186/1475-2875-8-272

Accesses  

  • Last 30 days: 86 accesses
  • Last 365 days: 694 accesses
  • All time: 2368 accesses

Cited by

BioMed Central: 1 citation

Research   Open Access Highly Accessed

Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

Hervé Menan, Oumar Faye, Albert Same-Ekobo, Agbaya Serge S Oga, Babacar Faye, Christiane P Kiki Barro, Thomas Kuete, Jean-Louis N'diaye, Ama-Moor Vicky, Rogert Tine, William Yavo, Dieynaba Kane, Kondo F Kassi, Moussa Kone Malaria Journal 2011, 10:185 (8 July 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

A randomized controlled trial of two artemisinin-based combinations for uncomplicated malaria.

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations